Busca un médico

Emmanuel M. Gabriel, M.D., Ph.D.

  1. General Surgeon
  2. Surgical Oncologist

Publicaciones

  1. Gabriel EM, Necela B, Bahr D, Vivekanandhan S, Shreeder B, Bagaria S, Knutson KL. Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma. Sci Rep. 2024 Oct 19; 14 (1):24545
    View PubMed
  2. Du H, Wang X, Xie S, Tartarone A, Gabriel E, Velotta JB, Pallante P, Zhu L, Hang J, Chen L. Identification of a prognostic DNA repair gene signature in esophageal cancer. J Gastrointest Oncol. 2024 Jun 30; 15 (3):829-840 Epub 2024 June 27
    View PubMed
  3. Gabriel EM, Bahr D, Rachamala HK, Madamsetty VS, Shreeder B, Bagaria S, Escobedo AL, Reid JM, Mukhopadhyay D. Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma. ACS Biomater Sci Eng. 2024 May 13; 10 (5):3412-3424 Epub 2024 Apr 13
    View PubMed
  4. Mubarak F, Kowkabany G, Popp R, Bansal S, Ahmed SH, Sharan S, Sukniam KB, Raikot SR, Jimenez PB, Popp K, Manaise HK, Gabriel E. Early Stage Breast Cancer: Does Histologic Subtype (Ductal vs. Lobular) Impact 5 Year Overall Survival? Cancers (Basel). 2024 Apr 15; 16 (8)
    View PubMed
  5. Sukniam K, Manaise HK, Popp K, Popp R, Gabriel E. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics. Cells. 2024 Mar 7; 13 (6) Epub 2024 Mar 07
    View PubMed
  6. Popp K, Popp R, Bansal S, Sharan S, Ahmed SH, Sukiam KB, Raikot S, Jimenez PB, Manaise HK, Kowkabany G, Gabriel EM. Disparities in Time-to-treatment for Patients With Melanoma. Anticancer Res. 2024 Feb; 44 (2):631-637
    View PubMed
  7. Sharan S, Bansal S, Manaise HK, Jimenez PB, Raikot SR, Ahmed SH, Popp R, Popp K, Sukniam K, Kowkabany G, Mubarak F, Gabriel E. Time to treatment disparities in gastric cancer patients in the United States of America: a comprehensive retrospective analysis. Front Oncol. 2024; 14:1292793 Epub 2024 Feb 09
    View PubMed
  8. Popp R, Bansal S, Sharan S, Ahmed SH, Sukniam KB, Raikot S, Popp K, Jimenez PB, Manaise HK, Kowkabany G, Attwood K, Gabriel EM. Disparities in time to treatment initiation for rectal cancer patients: an analysis of demographic and socioeconomic factors. Front Oncol. 2024; 14:1327400 Epub 2024 May 10
    View PubMed
  9. Chen WS, Lin J, Zhang WT, Chen WJ, Gabriel EM, Kuo PC, Caycedo-Marulanda A, Cai YQ, Chen XD, Wu WY. Effect of low-level creatinine clearance on short-term postoperative complications in patients with colorectal cancer. J Gastrointest Oncol. 2023 Dec 31; 14 (6):2409-2424 Epub 2023 Nov 28
    View PubMed
  10. Ahmed SH, Manaise HK, Popp R, Sharan S, Bansal S, Sukniam KB, Raikot SR, Kowkabany G, Jimenez PB, Popp K, Mubarak F, George A, Gabriel E. Disparities in Time to Treatment for Skin Cancer. Anticancer Res. 2023 Dec; 43 (12):5555-5562
    View PubMed
  11. Huang K, Dufresne M, Baksh M, Nussbaum S, Abbaszadeh Kasbi A, Mohammed A, Advani P, Morozov A, Bagaria S, McLaughlin S, Gabriel E. How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer? Am Surg. 2023 Dec; 89 (12):5414-5420 Epub 2023 Feb 14
    View PubMed
  12. Liu Z, Zhang Y, Ma N, Yang Y, Ma Y, Wang F, Wang Y, Wei J, Chen H, Tartarone A, Velotta JB, Dayyani F, Gabriel E, Wakefield CJ, Kidane B, Carbonelli C, Long L, Liu Z, Su J, Li Z. Progenitor-like exhausted SPRY1(+)CD8(+) T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell. 2023 Nov 13; 41 (11):1852-1870.e9 Epub 2023 Oct 12
    View PubMed
  13. Kowkabany G, Jimenez PB, Sharan S, Bansal S, Ahmed SH, Raikot S, Manaise HK, Popp R, Popp K, Sukniam KB, Gabriel E. Inequities in Time to Treat Thyroid Cancer. Anticancer Res. 2023 Nov; 43 (11):5025-5030
    View PubMed
  14. Jimenez PB, Popp R, Sharan S, Manaise HK, Ahmed SH, Bansal S, Kowkabany G, Raikot S, DO KBS, George A, Gabriel E. Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer. Anticancer Res. 2023 Nov; 43 (11):4969-4974
    View PubMed
  15. Huang K, Jakub J, Gabriel E, Moreno-Aspitia A, McLaughlin S. ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer. Ann Surg Oncol. 2023 Nov; 30 (12):7143
    View PubMed
  16. Huang K, Jakub J, Gabriel E, Moreno-Aspitia A, McLaughlin S. Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer. Ann Surg Oncol. 2023 Nov; 30 (12):7026-7035 Epub 2023 July 25
    View PubMed
  17. Knewitz D, Almerey T, Gabriel E. A narrative review of prognostic indices in the evaluation of gastrointestinal cancers. J Gastrointest Oncol. 2023 Aug 31; 14 (4):1849-1855 Epub 2023 July 05
    View PubMed
  18. Mohammed T, Gosain R, Rana N, Lemini R, Wang K, Agha A, Neupane A, Gabriel EM, Nurkin S, Boland P. Geographic and Demographic Disparities in Colorectal Cancer: A National Cancer Database Analysis. Hematol Oncol Stem Cell Ther. 2023 Apr 4; 16 (3):262-271 Epub 2023 Apr 04
    View PubMed
  19. Vivekanandhan S, Bahr D, Kothari A, Ashary MA, Baksh M, Gabriel E. Immunotherapies in rare cancers. Mol Cancer. 2023 Feb 1; 22 (1):23 Epub 2023 Feb 01
    View PubMed
  20. Asbun D, Cheng YL, Bush W, Samson SL, Meek S, Paz-Fumagalli R, Lewis A, Gabriel E, Asbun H, Rao SN, Elli EF. Eleven-Year Experience with Selective Adrenal Vein Sampling in Management of Primary Adrenal Hormonal Hypersecretion. J Laparoendosc Adv Surg Tech A. 2023 Feb; 33(2):129-136. Epub 2022 Nov 01.
    View PubMed
  21. Kaplan JL, Turker I, Chumsri S, Gabriel E. Abscopal Effect Following Cryoablation in a Patient with Metastatic Breast Cancer. Front Biosci (Schol Ed). 2023 Jan 16; 15 (1):2
    View PubMed
  22. Gabriel EM, Sukniam K, Popp K, Bagaria SP. Human intravital microscopy in the study of sarcomas: an early trial of feasibility. Front Oncol. 2023; 13:1151255 Epub 2023 Apr 12
    View PubMed
  23. Sukniam K, Kasbi AA, Ashary MA, Popp K, Attwood K, George A, Gabriel E. Disparities in Time to Treatment for Breast Cancer. Anticancer Res. 2022 Dec; 42 (12):5813-5818
    View PubMed
  24. Zhang P, Hou X, Cai B, Yu W, Chen J, Huang X, Li Y, Zeng M, Ren Z, Gabriel E, Qu B, Liu F. Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world. Ann Transl Med. 2022 Jun; 10 (12):708
    View PubMed
  25. Nussbaum S, Shoukry M, Ashary MA, Kasbi AA, Baksh M, Gabriel E. Advanced Tumor Imaging Approaches in Human Tumors. Cancers (Basel). 2022 Mar 18; 14 (6)
    View PubMed
  26. Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol. 2022 Mar 17 [Epub ahead of print]
    View PubMed
  27. Broccard SP, Kasbi AA, Bagaria SP, Jones J, Shoudry M, Gabriel EM. Liquid biopsies for colorectal cancer: a narrative review of ongoing clinical trials and the current use of this technology at a comprehensive cancer center. J Gastrointest Oncol. 2022 Feb; 13(1):438-449.
    View PubMed
  28. Baksh M, Mahajan B, Dufresne MM, Shoukry MM, Nussbaum S, Abbaszadeh-Kasbi A, Ashary M, Vandenberg J, Gabriel EM. Circulating tumor DNA for breast cancer: Review of active clinical trials. Cancer Treat Res Commun. 2022; 32:100609 Epub 2022 July 12
    View PubMed
  29. Abbaszadeh Kasbi A, Ashary MA, Baksh M, Nussbaum S, Attwood K, Gabriel E. Age-related Survival Outcomes for Pancreatic Cancer by Age. Cancer Diagn Progn. 2022 Jan-Feb; 2 (1):71-77 Epub 2022 Jan 03
    View PubMed
  30. Yu Y, Wang W, Qin Z, Li H, Liu Q, Ma H, Sun H, Bauer TL, Pimiento JM, Gabriel E, Birdas T, Li Y, Xing W. A clinical nomogram for predicting tumor regression grade in esophageal squamous-cell carcinoma treated with immune neoadjuvant immunotherapy. Ann Transl Med. 2022 Jan; 10 (2):102
    View PubMed
  31. Deng L, Groman A, Jiang C, Perimbeti S, Gabriel E, Kukar M, Mukherjee S. Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma. JAMA Netw Open. 2021 Nov 1; 4 (11):e2135340 Epub 2021 Nov 01
    View PubMed
  32. Shoukry M, Kaplan JL, Mangum CA, Bagaria S, Gabriel E. Management of a Primary Retroperitoneal Yolk Sac Tumor. Am J Case Rep. 2021 Oct 27; 22:e933258
    View PubMed
  33. Lemini R, Diaz Vico T, Trumbull DA, Attwood K, Spaulding AC, Elli EF, Colibaseanu DT, Kukar M, Gabriel E. Prognostic models for stage I-III esophageal cancer: a comparison between existing calculators. J Gastrointest Oncol. 2021 Oct; 12 (5):1963-1972
    View PubMed
  34. Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol. 2021 Oct; 28 (11):6882-6889 Epub 2021 Mar 19
    View PubMed
  35. Huang K, Misra S, Bagaria SP, Gabriel EM. Outcomes of patients with invasive mucinous and tubular carcinomas of the breast. Breast J. 2021 Sep; 27 (9):691-699 Epub 2021 June 25
    View PubMed
  36. Tolaymat LM, Reimer DK, Feig J, Gillis MS, Speicher LL, Haga CB, Gabriel EM, Heckman MG, Yin M, Fosko SW, Keaveny AP, Dawson NL. Skin cancer in non-white liver transplant recipients: Mayo Clinic experience. Int J Dermatol. 2021 Aug; 60(8):986-990. Epub 2021 Mar 20.
    View PubMed
  37. Shoukry M, Broccard S, Kaplan J, Gabriel E. The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer. Cancers (Basel). 2021 Jul 29; 13 (15) Epub 2021 July 29
    View PubMed
  38. Seneviratne D, Vallow LA, Gunn JL, Gibson TC, Gabriel E, Bagaria SP, McLaughlin SA. The Management of Positive Axillary Nodes in Early Stage Breast Cancer: Analysis of Practice Pattern Concordance with Landmark Trials Journal of Surgery. 2021; 9(3):114-120.
  39. Kaplan J, Mangum C, Shoukry M, Gabriel E. Inflammatory Pseudotumor Resembling a Malignant Pancreatic Disease Process. Anticancer Res. 2021 Apr; 41 (4):2079-2082
    View PubMed
  40. Gabriel EM, Kim M, Fisher DT, Mangum C, Attwood K, Ji W, Mukhopadhyay D, Bagaria SP, Robertson MW, Dinh TA, Knutson KL, Skitzki JJ, Wallace MB. A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis. Sci Rep. 2021 Mar 2; 11 (1):4946 Epub 2021 Mar 02
    View PubMed
  41. Trumbull DA, Lemini R, Diaz Vico T, Jorgensen MS, Attwood K, Ji W, Brady M, Gabriel E, Kukar M. Prognostic Significance of Complete Pathologic Response Obtained with Chemotherapy Versus Chemoradiotherapy in Gastric Cancer. Ann Surg Oncol. 2021 Feb; 28 (2):766-773 Epub 2020 July 31
    View PubMed
  42. Trumbull DA, Gabriel E, Kukar M. ASO Author Reflections: Does Overall Survival Benefit From Complete Pathologic Responders Vary With Treatment Approach? Ann Surg Oncol. 2020 Dec; 27 (Suppl 3):888-889 Epub 2020 Aug 10
    View PubMed
  43. Trumbull D, Lemini R, Elli EF, Bagaria SP, Attwood K, Gabriel E. Age-Based Trends of Gastric Adenocarcinoma in the United States. Am Surg. 2020 Dec; 86 (12):1721-1727 Epub 2020 Aug 31
    View PubMed
  44. Huang K, Misra S, Lemini R, Chen Y, Speicher LL, Dawson NL, Tolaymat LM, Bagaria SP, Gabriel EM. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma. J Surg Oncol. 2020 Nov; 122 (6):1057-1065 Epub 2020 July 11
    View PubMed
  45. Trumbull D, Lemini R, Attwood K, Kukar M, Gabriel E. Gastric Cancer Disparities Among Asian American Subpopulations. Anticancer Res. 2020 Nov; 40 (11):6381-6385
    View PubMed
  46. Trumbull DA, Lemini R, Bagaria SP, Elli EF, Colibaseanu DT, Wallace MB, Gabriel E. Intravital Microscopy (IVM) in Human Solid Tumors: Novel Protocol to Examine Tumor-Associated Vessels. JMIR Res Protoc. 2020 Oct 9; 9 (10):e15677 Epub 2020 Oct 09
    View PubMed
  47. Osagiede O, Habermann E, Day C, Gabriel E, Merchea A, Lemini R, Jabbal IS, Colibaseanu DT. Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections. J Gastrointest Oncol. 2020 Oct; 11 (5):836-846
    View PubMed
  48. Gabriel EM, Kim M, Fisher DT, Powers C, Attwood K, Bagaria SP, Knutson KL, Skitzki JJ. Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma. Sci Rep. 2020 Aug 6; 10 (1):13245 Epub 2020 Aug 06
    View PubMed
  49. Narayanan S, Attwood K, Gabriel E, Nurkin S. Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer. J Surg Res. 2020 Jul; 251:220-227 Epub 2020 Mar 12
    View PubMed
  50. Gunn J, Lemini R, Partain K, Yeager T, Almerey T, Attwood K, McLaughlin S, Bagaria SP, Gabriel E. Trends in utilization of sentinel node biopsy and adjuvant radiation in women >/= 70. Breast J. 2020 Jul; 26 (7):1321-1329 Epub 2020 Jan 06
    View PubMed
  51. Moro K, Sakata E, Nakahara A, Hashidate H, Gabriel E, Makino H. Malignant adenomyoepithelioma of the breast. Surg Case Rep. 2020 May 29; 6 (1):118
    View PubMed
  52. Trumbull D, Lemini R, F Elli E, P Bagaria S, Attwood K, Gabriel E. Age-Based Trends of Gastric Adenocarcinoma in the United States. Am Surg. 2020 May; 86 (5):407-414
    View PubMed
  53. Lemini R, Jorgensen MS, Attwood K, Almerey T, Elli EF, Colibaseanu DT, Bagaria SP, Gabriel E. Racial Disparities in Outcomes Among Asians With Gastric Cancer in the USA. Anticancer Res. 2020 Feb; 40 (2):881-889
    View PubMed
  54. Huayllani MT, Bagaria SP, Restrepo DJ, Boczar D, Sisti A, Cochuyt JJ, Spaulding AC, Gabriel EM, Rinker BD, Forte AJ. Residual Tumor on Wide Excisional Margins After Treatment of Invasive Melanoma. Anticancer Res. 2020 Feb; 40 (2):1059-1063
    View PubMed
  55. Rana N, Gosain R, Lemini R, Wang C, Gabriel E, Mohammed T, Siromoni B, Mukherjee S. Socio-Demographic Disparities in Gastric Adenocarcinoma: A Population-Based Study. Cancers (Basel). 2020 Jan 9; 12 (1) Epub 2020 Jan 09
    View PubMed
  56. Huang K, Xu Y, Gabriel EM, Misra S, Chen Y, Bagaria SP. Comparative Analysis of Acral Melanoma in Chinese and Caucasian Patients. J Skin Cancer. 2020; 2020:5169051 Epub 2020 Oct 06
    View PubMed
  57. Boczar D, Restrepo DJ, Sisti A, Huayllani MT, Spaulding AC, Gabriel E, Bagaria S, Parker AS, Leppin AL, Forte AJ. Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis. Anticancer Res. 2019 Dec; 39 (12):6877-6880
    View PubMed
  58. Boczar D, Restrepo DJ, Sisti A, Huayllani MT, Spaulding AC, Gabriel E, Bagaria S, McLaughlin S, Parker AS, Forte AJ. Influence of Facility Characteristics on Access to Breast Reconstruction: A 12-Year National Cancer Database Analysis. Anticancer Res. 2019 Dec; 39 (12):6881-6885
    View PubMed
  59. Lemini R, Attwood K, Almerey T, Gunn J, Yeager TE, Elias AW, Partain K, Jorgensen MS, Ji W, Gabriel EM, Colibaseanu DT. Is metastasectomy a worthy option?-the role of surgery in metastatic colon cancer to liver and lungs. J Gastrointest Oncol. 2019 Dec; 10 (6):1032-1048
    View PubMed
  60. Oliver JD, Boczar D, Sisti A, Huayllani MT, Restrepo DJ, Spaulding AC, Gabriel E, Bagaria S, Rinker BD, Forte AJ. Eyelid Melanoma in the United States: A National Cancer Database Analysis. J Craniofac Surg. 2019 Nov-Dec; 30 (8):2412-2415
    View PubMed
  61. Oliver JD, Boczar D, Sisti A, Huayllani MT, Restrepo DJ, Spaulding AC, Gabriel E, Bagaria S, Rinker BD, Forte AJ. National Analysis of Patients With External Ear Melanoma in the United States. J Craniofac Surg. 2019 Nov-Dec; 30 (8):e787-e790
    View PubMed
  62. Restrepo DJ, Huayllani MT, Boczar D, Sisti A, Gabriel E, Lemini R, Spaulding AC, Bagaria S, Manrique OJ, Forte AJ. Biopsy Type Disparities in Patients With Melanoma: Who Receives the Standard of Care? Anticancer Res. 2019 Nov; 39 (11):6359-6363
    View PubMed
  63. Restrepo DJ, Sisti A, Boczar D, Huayllani MT, Fishe J, Gabriel E, McLaughlin SA, Bagaria S, Spaulding A, Rinker BD, Forte AJ. Characteristics of Breast Cancer Patients Who Refuse Surgery. Anticancer Res. 2019 Sep; 39 (9):4941-4945
    View PubMed
  64. Moro K, Nagahashi M, Gabriel E, Takabe K, Wakai T. Clinical application of ceramide in cancer treatment. Breast Cancer. 2019 Jul; 26 (4):407-415 Epub 2019 Apr 08
    View PubMed
  65. Oliver JD, Boczar D, Sisti A, Huayllani MT, Restrepo DJ, Spaulding AC, Gabriel E, Bagaria S, Rinker BD, Forte AJ. Eyelid Melanoma in the United States: A National Cancer Database Analysis. J Craniofac Surg. 2019 Jun 20 Epub 2019 June 20
    View PubMed
  66. Restrepo DJ, Boczar D, Huayllani MT, Sisti A, Gabriel E, McLaughlin SA, Bagaria S, Spaulding AC, Rinker BD, Forte AJ. Influence of Race, Income, Insurance, and Education on the Rate of Breast Reconstruction. Anticancer Res. 2019 Jun; 39 (6):2969-2973
    View PubMed
  67. Gabriel E, Elli E, Bagaria S, Wasif N, Grotz T, Stauffer J, Kasi PM, Asbun H. Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). J Robot Surg. 2019 Feb; 13 (1):175-179 Epub 2018 May 05
    View PubMed
  68. Moro K, Kameyama H, Abe K, Tsuchida J, Tajima Y, Ichikawa H, Nakano M, Ikarashi M, Nagahashi M, Shimada Y, Kato K, Okamoto T, Umezu H, Gabriel E, Tsuchida M, Wakai T. Left colic artery aneurysm rupture after stent placement for abdominal aortic aneurysm associated with neurofibromatosis type 1. Surg Case Rep. 2019 Jan 23; 5 (1):12
    View PubMed
  69. Sroka R, Gabriel EM, Al-Hadidi D, Nurkin SJ, Urman RD, Quinn TD. A novel anesthesiologist-led multidisciplinary model for evaluating high-risk surgical patients at a comprehensive cancer center. J Healthc Risk Manag. 2019 Jan; 38 (3):12-23 Epub 2018 July 23
    View PubMed
  70. Lemini R, Attwood K, Pecenka S, Grego J, Spaulding AC, Nurkin S, Colibaseanu DT, Gabriel E. Stage II-III colon cancer: a comparison of survival calculators. J Gastrointest Oncol. 2018 Dec; 9 (6):1091-1098
    View PubMed
  71. Narayanan S, Gabriel E, Attwood K, Boland P, Nurkin S. Association of Clinicopathologic and Molecular Markers on Stage-specific Survival of Right Versus Left Colon Cancer. Clin Colorectal Cancer. 2018 Dec; 17 (4):e671-e678 Epub 2018 July 05
    View PubMed
  72. Almerey T, Gabriel EM, Torp KD, Bagaria SP. Intraoperative fluid restriction in hyperthermic intraperitoneal chemotherapy. J Surg Res. 2018 Nov; 231:77-82 Epub 2018 June 09
    View PubMed
  73. Kukar M, Gabriel E, Ben-David K, Hochwald SN. Laparoscopic proximal gastrectomy for gastric neoplasms. J Surg Oncol. 2018 Jul; 118 (1):95-100 Epub 2018 June 19
    View PubMed
  74. Gabriel E, Narayanan S, Attwood K, Hochwald S, Kukar M, Nurkin S. Disparities in major surgery for esophagogastric cancer among hospitals by case volume. J Gastrointest Oncol. 2018 Jun; 9 (3):503-516
    View PubMed
  75. Gabriel EM, Fisher DT, Evans S, Takabe K, Skitzki JJ. Intravital microscopy in the study of the tumor microenvironment: from bench to human application. Oncotarget. 2018 Apr 13; 9 (28):20165-20178
    View PubMed
  76. Gabriel E, Shah R, Attwood K, Kukar M, Hochwald S. The first postesophagectomy chest X-ray predicts respiratory failure and the need for tracheostomy. J Surg Res. 2018 Apr; 224:89-96 Epub 2017 Dec 22
    View PubMed
  77. Gabriel E, Kim J, Ostapoff KT, Attwood K, Kurenov S, Kuvshinoff B, Hochwald SN, Nurkin SJ. Preoperative survival calculator for resectable hepatocellular carcinoma. J Gastrointest Oncol. 2018 Apr; 9 (2):316-325
    View PubMed
  78. Gabriel E, Attwood K, Narayanan S, Brady M, Nurkin S, Hochwald S, Kukar M. Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma? J Surg Oncol. 2018 Mar; 117 (4):659-670 Epub 2017 Nov 11
    View PubMed
  79. Singla S, Gabriel E, Alnaji R, Du W, Attwood K, Nava H, Hochwald SN, Kukar M. Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer. J Gastrointest Oncol. 2018 Feb; 9 (1):73-79
    View PubMed
  80. Gabriel E, Attwood K, Al-Sukhni E, Erwin D, Boland P, Nurkin S. Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol. 2018 Feb; 9 (1):96-110
    View PubMed
  81. Bagaria SP, Neville M, Gray RJ, Gabriel E, Ashman JB, Attia S, Wasif N. The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions. Sarcoma. 2018; 2018:3056562 Epub 2018 July 24
    View PubMed
  82. Gabriel E, Bagaria SP. Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction. Front Oncol. 2018; 8:297 Epub 2018 Aug 06
    View PubMed
  83. Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol. 2018 Jan; 117 (1):62-68 Epub 2017 Dec 19
    View PubMed
  84. Shahab D, Gabriel E, Attwood K, Ma WW, Francescutti V, Nurkin S, Boland PM. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation. Clin Colorectal Cancer. 2017 Dec; 16 (4):300-307 Epub 2017 Mar 18
    View PubMed
  85. Moro K, Nagahashi M, Naito T, Nagai Y, Katada T, Minagawa M, Hasegawa J, Tani T, Shimakage N, Usuda H, Gabriel E, Kawaguchi T, Takabe K, Wakai T. Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor: a case of a rare malignancy. Surg Case Rep. 2017 Dec; 3 (1):67 Epub 2017 May 11
    View PubMed
  86. Kukar M, Gabriel E, May R, Cho E, Lichtenthal M, Groman A, Skitzki J, Francescutti V, Kane JM 3rd. Conditional Survival-Based "Abbreviated" Routine Cancer Surveillance for Pathologic Stage IB Melanoma. Am Surg. 2017 Nov 1; 83 (11):1256-1262
    View PubMed
  87. Moro K, Kawahara M, Muneoka Y, Sato Y, Kitami C, Makino S, Nishimura A, Kawachi Y, Gabriel E, Nikkuni K. Right-sided Bochdalek hernia in an elderly adult: a case report with a review of surgical management. Surg Case Rep. 2017 Oct 13; 3 (1):109
    View PubMed
  88. Gabriel E, Singla S, Kim M, Fisher D, Powers C, Visioni A, Attwood K, Skitzki J. Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Am J Surg. 2017 Sep; 214 (3):462-467 Epub 2017 June 06
    View PubMed
  89. Gabriel E, Rosso K, Shahab D, Shah R, Bain A, Kukar M, Hochwald SN. Laparoscopic Intragastric Surgery With Endoscopic Assistance: A 2 Gastrostomy Approach With Multiple Applications. Surg Laparosc Endosc Percutan Tech. 2017 Jul 20 Epub 2017 July 20
    View PubMed
  90. Ostapoff KT, Gabriel E, Attwood K, Kuvshinoff BW, Nurkin SJ, Hochwald SN. Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma? HPB (Oxford). 2017 Jul; 19 (7):587-594 Epub 2017 Apr 19
    View PubMed
  91. Gabriel E, Alnaji R, Du W, Attwood K, Kukar M, Hochwald S. Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer. Ann Surg Oncol. 2017 Jun; 24 (6):1739-1746 Epub 2017 Jan 05
    View PubMed
  92. Gabriel E, Ostapoff K, Attwood K, Al-Sukhni E, Boland P, Nurkin S. Disparities in the Age-Related Rates of Colorectal Cancer in the United States. Am Surg. 2017 Jun 01; 83 (6):640-647
    View PubMed
  93. Gabriel E, Attwood K, Shah R, Nurkin S, Hochwald S, Kukar M. Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma. J Am Coll Surg. 2017 May; 224 (5):884-894.e1 Epub 2017 Jan 29
    View PubMed
  94. Visioni A, Shah R, Gabriel E, Attwood K, Kukar M, Nurkin S. Enhanced Recovery After Surgery for Noncolorectal Surgery?: A Systematic Review and Meta-analysis of Major Abdominal Surgery. Ann Surg. 2017 Apr 21 [Epub ahead of print]
    View PubMed
  95. Gabriel E, Kukar M, Groman A, Alvarez-Perez A, Schneider J, Francescutti V. A Formal Palliative Care Service Improves the Quality of Care in Patients with Stage IV Cancer and Bowel Obstruction. Am J Hosp Palliat Care. 2017 Feb; 34 (1):20-25 Epub 2016 July 10
    View PubMed
  96. Berkley BS, Gabriel E. Disparities in Robotic Surgery for Gastrointestinal Cancers. Scientific Pages Robot.2017;1:(1):8-9.
  97. Gabriel E, Thirunavukarasu P, Attwood K, Nurkin SJ. National disparities in minimally invasive surgery for pancreatic tumors. Surg Endosc. 2017 Jan; 31 (1):398-409 Epub 2016 July 13
    View PubMed
  98. Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study. Int J Surg. 2017 Jan; 37:42-49 Epub 2016 Sept 04
    View PubMed
  99. Gabriel E, Al-Sukhni E, Nurkin S. Commentary on "Insurance Status, Not Race, is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer". Ann Surg. 2016 Dec 12 [Epub ahead of print]
    View PubMed
  100. Al-Sukhni E, Gabriel E, Attwood K, Kukar M, Nurkin SJ, Hochwald SN. No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base. J Am Coll Surg. 2016 Dec; 223 (6):784-792.e1 Epub 2016 Sept 15
    View PubMed
  101. Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ. National Disparities in Surgical Approach to T1 Rectal Cancer and Impact on Outcomes. Am Surg. 2016 Nov 01; 82 (11):1080-1091
    View PubMed
  102. Alnaji RM, Du W, Gabriel E, Singla S, Attwood K, Nava H, Malhotra U, Hochwald SN, Kukar M. Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma. J Gastrointest Surg. 2016 Sep; 20 (9):1541-6 Epub 2016 June 03
    View PubMed
  103. Baldwin S, Kukar M, Gabriel E, Attwood K, Wilkinson N, Hochwald SN, Kuvshinoff B. Pancreatic cancer metastatic to a limited number of lymph nodes has no impact on outcome. HPB (Oxford). 2016 Jun; 18 (6):523-8
    View PubMed
  104. Al-Sukhni E, Attwood K, Mattson DM, Gabriel E, Nurkin SJ. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Ann Surg Oncol. 2016 Apr; 23 (4):1177-86 Epub 2015 Dec 14
    View PubMed
  105. Al-Sukhni E, Attwood K, Gabriel E, Nurkin SJ. Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database. Int J Surg. 2016 Apr; 28:112-7 Epub 2016 Feb 21
    View PubMed
  106. Gabriel E, Attwood K, Young J, Cappuccino H, Kumar S. Impact of American College of Surgeons Oncology Group Z11 on surgical training at an academic cancer center. J Surg Res. 2016 Apr; 201 (2):266-71 Epub 2015 Nov 30
    View PubMed
  107. Gabriel E, Thirunavukarasu P, Al-Sukhni E, Attwood K, Nurkin SJ. National disparities in minimally invasive surgery for rectal cancer. Surg Endosc. 2016 Mar; 30 (3):1060-7 Epub 2015 June 20
    View PubMed
  108. Gabriel E, Attwood K, Du W, Tuttle R, Alnaji RM, Nurkin S, Malhotra U, Hochwald SN, Kukar M. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation. JAMA Surg. 2016 Mar; 151 (3):234-45
    View PubMed
  109. Gabriel E, Attwood K, Thirunavukarasu P, Al-Sukhni E, Boland P, Nurkin S. Predicting Individualized Postoperative Survival for Stage II/III Colon Cancer Using a Mobile Application Derived from the National Cancer Data Base. J Am Coll Surg. 2016 Mar; 222 (3):232-44 Epub 2015 Dec 23
    View PubMed
  110. Shahab D, Gabriel E, Kukar M, Bain A, Hochwald S. Gastritis Cystica Profunda: A Challenging Disease Diagnosed Using a Novel Approach Open J Clin Med Case Rep.2016;2:(24):2379.
  111. Gabriel E, Al-Sukhni E, Azabdaftari G, Kukar M, Hochwald S. The Role of Surgery Metastatic ACTH-producing Pancreatic Neuroendocrine Tumors Open J Clin Med Case Rep.2016;2:(19):1171.
  112. Al-Sukhni E, Gabriel E, Qiu J, Hochwald S. Sarcoidosis Presenting with Primary Pancreatic Manifestations: A Case Report and Review of the Literature J Mol Biomark Diagn.2016;7:290.
  113. Gabriel E, Al-Sukhni E, Kukar M, Hochwald S. Intraductal Tubulopapillary Neoplasm: An Unusual Presentation of a Rare Tumor J Mol Biomark Diagn.2016;7:286.
  114. Thirunavukarasu P, Gabriel E, Attwood K, Kukar M, Hochwald SN, Nurkin SJ. Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy. Int J Surg. 2016 Jan; 25:69-75 Epub 2015 Nov 18
    View PubMed
  115. Gabriel E, Skitzki J. The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options. Cancers (Basel). 2015 Jul 01; 7 (3):1154-77 Epub 2015 July 01
    View PubMed
  116. Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Ann Surg Oncol. 2015 Jan; 22 (1):90-5 Epub 2014 Sept 24
    View PubMed
  117. Gabriel EM, Iyer R. Biliary cancer: Current Management and Emerging Targeted Therapies J Targeted Ther.2014;3:(6):32-41.
  118. Gabriel EM, Savu M. Discovery of a rare ileocecal plasmacytoma. J Surg Case Rep. 2014 Mar 30; 2014 (3)
    View PubMed
  119. Gabriel EM, Jatoi I. Breast cancer chemoprevention. Expert Rev Anticancer Ther. 2012 Feb; 12 (2):223-8
    View PubMed
  120. Goydos JS, Mann B, Kim HJ, Gabriel EM, Alsina J, Germino FJ, Shih W, Gorski DH. Detection of B-RAF and N-RAS mutations in human melanoma. J Am Coll Surg. 2005 Mar; 200 (3):362-70
    View PubMed
  121. Gabriel EM, Campbell WC. Effect of ambient salinity on immobilization of Caenorhabditis elegans by nematocidal agents. Parasitol Res. 2003 Aug; 90 (5):390-2 Epub 2003 May 09
    View PubMed
PST-20341356